Connect Biopharma to present data on rademikibart for asthma and COPD at ATS 2025, initiating Phase 2 trials in 2025. Connect Biopharma Holdings Limited announced its plans to present four posters at ...
Location: San Diego Convention Center, Room 31A-C (Upper Level) Additionally, the poster presentation will be available as an ePoster on the ATS 2024 International Conference website, and will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results